Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › ABEO

SILVERARC CAPITAL MANAGEMENT, LLC position in ABEO

ABEONA THERAPEUTICS INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 693,441 shares of ABEO (ABEONA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.46% of its reported portfolio and ranking #44 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ABEO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)693.44K sh
Reported value held$3.64M
Portfolio Weight0.46%
First reportedQ2 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's ABEO position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in ABEO in Q2 2025 at 917,898 shares (US$5.2M). The position peaked in Q3 2025 at 994,754 shares, worth US$5.3M. Across 6 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 693,441 shares valued at US$3.6M — an increase of 83,034 shares quarter over quarter.. Notable position changes include a 37% trim in Q4 2025 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 917.90K $5.21M New
Q3 2025 994.75K $5.25M Add
Q4 2025 627.74K $3.31M Reduce
Q1 2026 648.94K $2.91M Add
Q2 2026 610.41K $3.77M Reduce
Q3 2026 693.44K $3.64M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABEO and 13F data

ABEO (ABEONA THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in ABEO — the largest reported positions include Cable Car Capital, LP (US$18.6M), AIGH Capital Management LLC (US$15.2M), AWM Investment Company, Inc. (US$9.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABEO

All ABEO fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held ABEO?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ABEO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in ABEO?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 693.44K shares of ABEO (ABEONA THERAPEUTICS INC), valued at $3.64M, representing 0.46% of its reported portfolio and ranking #44.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling ABEO?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in ABEO. The position peaked in Q3 2025 at 994.75K shares.

Which other funds hold ABEO?

Other major institutional holders of ABEO include Cable Car Capital, LP, AIGH Capital Management LLC, AWM Investment Company, Inc., among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.